Respiratory Monitoring Market to Reach USD 6.02 Billion by 2033 | North America Holds 38.4% Market Share | Key Players: GE HealthCare, Medtronic plc, Masimo Corporation

The global respiratory monitoring market was valued at USD 2.86 billion in 2025 and is projected to reach USD 6.02 billion by 2033, growing at a CAGR of 9.6% during the forecast period from 2026 to 2033. The market is experiencing strong growth driven by the rising prevalence of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and respiratory infections, along with increasing demand for continuous patient monitoring across hospitals, ambulatory care centers, and home healthcare settings. Respiratory monitoring technologies are gaining significant importance due to the growing focus on early disease detection, real time patient monitoring, and improved critical care management. Increasing adoption of wearable respiratory monitoring devices, pulse oximeters, capnography systems, spirometers, and AI powered remote patient monitoring solutions is further accelerating market expansion globally. In addition, the growing aging population, rising ICU admissions, increasing demand for telehealth services, and rapid digital transformation in healthcare infrastructure are creating strong long term growth opportunities across developed and emerging economies.

The market is also benefiting from continuous advancements in wireless biosensors, cloud connected monitoring platforms, AI enabled predictive analytics, and non invasive respiratory assessment technologies aimed at improving patient outcomes and reducing hospital burden. Several major investments, partnerships, and product innovations are reshaping the industry landscape. Recently, Philips partnered with Respiree to expand AI enabled cardio respiratory monitoring solutions across hospital and home care environments, strengthening the adoption of connected respiratory surveillance systems. In another major development, ProSomnus Sleep Technologies received FDA Class II clearance for its RPMO2 OSA device, integrating sleep apnea therapy with advanced physiological respiratory monitoring capabilities. Additionally, Danaher Corporation announced the acquisition of Masimo to strengthen its patient monitoring and diagnostic portfolio, highlighting the growing strategic importance of respiratory monitoring technologies worldwide. Leading companies including ResMed Inc., Medtronic, GE HealthCare, Masimo Corporation, and Koninklijke Philips N.V. are actively investing in AI driven monitoring systems, wearable respiratory devices, cloud based healthcare integration, and remote patient monitoring technologies to strengthen their market position. Rising demand for home based respiratory care, continuous oxygen saturation monitoring, sleep disorder management, and connected healthcare ecosystems is expected to significantly support the long term development of the global respiratory monitoring market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/research-report/-respiratory-monitoring-market?sai-v

Key Developments
April 2026: Masimo expanded its advanced respiratory monitoring portfolio with enhanced continuous capnography and pulse oximetry technologies for critical care and remote patient monitoring applications, supporting improved respiratory disease management across hospitals and ambulatory care settings.

March 2026: Philips launched next-generation AI-enabled respiratory monitoring systems across Europe and North America, focusing on early detection of respiratory deterioration and real-time patient surveillance in intensive care environments.

February 2026: Medtronic strengthened its respiratory monitoring capabilities through new integrated ventilation and patient monitoring solutions, supporting advanced respiratory care management in acute and chronic disease treatment applications.

December 2025: GE HealthCare expanded respiratory monitoring technology deployments across Asia Pacific healthcare facilities, focusing on multi-parameter monitoring systems for neonatal, pediatric, and adult critical care applications.

October 2025: Dräger introduced advanced respiratory gas monitoring and ventilation monitoring systems across global healthcare markets, enhancing precision monitoring capabilities for surgical and intensive care procedures.

September 2025: The United States increased investments in remote respiratory monitoring infrastructure and connected healthcare technologies, supporting rising demand for home-based respiratory care and chronic pulmonary disease management solutions.

July 2025: Nihon Kohden expanded production capacity for respiratory monitoring devices across Japan and Southeast Asia, addressing growing demand for ICU monitoring systems and emergency respiratory care technologies.

May 2025: Europe accelerated adoption of wireless respiratory monitoring technologies across Germany, France, and the United Kingdom, supporting digital healthcare transformation and improved patient monitoring efficiency in hospitals and outpatient facilities.

March 2025: Smiths Medical enhanced its respiratory monitoring product portfolio with advanced capnography solutions and integrated airway monitoring technologies for emergency and perioperative care applications.

January 2025: China strengthened investments in critical care infrastructure and respiratory monitoring technologies across major healthcare institutions, supporting increased adoption of continuous respiratory surveillance systems and smart hospital development initiatives.

Key Players
GE HealthCare | Smith & Nephew | Vyaire Medical, Inc. | Masimo Corporation | Medtronic plc | Smiths Medical | COSMED | Nihon Kohden Corporation | Koninklijke Philips N.V. | Novelda AS | Others

Key Highlights
GE HealthCare - Holds a 16.8% share, driven by advanced patient monitoring technologies, integrated hospital diagnostic solutions, and strong global healthcare infrastructure presence.

Smith & Nephew - Holds a 11.7% share, supported by innovative respiratory care product integration, strong clinical technology capabilities, and expanding hospital partnership networks.

Vyaire Medical, Inc. - Holds a 13.4% share, strengthened by specialized respiratory monitoring systems, critical care ventilation expertise, and broad pulmonary diagnostics portfolio.

Masimo Corporation - Holds a 10.9% share, fueled by advanced noninvasive monitoring technologies, strong pulse oximetry innovation, and expanding remote patient monitoring adoption.

Medtronic plc - Holds a 12.6% share, driven by integrated respiratory monitoring devices, strong critical care solutions portfolio, and extensive global medical technology distribution channels.

Smiths Medical - Holds a 7.8% share, supported by comprehensive airway management technologies, hospital-focused monitoring solutions, and advanced infusion and respiratory care capabilities.

COSMED - Holds a 5.9% share, powered by advanced pulmonary function testing systems, metabolic monitoring expertise, and strong sports and clinical diagnostics applications.

Nihon Kohden Corporation - Holds a 6.3% share, strengthened by integrated patient monitoring systems, critical care diagnostic technologies, and expanding respiratory monitoring product innovations.

Koninklijke Philips N.V. - Holds a 9.1% share, driven by connected healthcare ecosystems, AI-enabled respiratory monitoring technologies, and strong sleep and respiratory care product offerings.

Novelda AS - Holds a 2.7% share, supported by ultra-wideband sensor innovations, contactless respiratory monitoring technologies, and growing wearable healthcare applications.

Others - Hold a combined 3.8% share, comprising regional respiratory device manufacturers, emerging digital health companies, sensor technology startups, and specialized critical care monitoring providers expanding advanced respiratory monitoring applications globally.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=-respiratory-monitoring-market?sai-v

Market Drivers

Increasing prevalence of chronic respiratory diseases, asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea is significantly driving growth of the respiratory monitoring market worldwide.

Growing demand for continuous patient monitoring in hospitals, intensive care units, and home healthcare settings is accelerating market expansion globally.

Rising geriatric population and increasing incidence of age-related respiratory disorders are strengthening demand for advanced respiratory monitoring devices across healthcare facilities.

Increasing adoption of remote patient monitoring, telehealth platforms, and wearable respiratory monitoring technologies is contributing to rapid commercialization of connected healthcare solutions.

Continuous advancements in AI-powered monitoring systems, wireless sensors, cloud-based analytics, and real-time respiratory assessment technologies are improving diagnostic accuracy and patient outcomes.

Expansion of critical care infrastructure, emergency healthcare services, and post-operative respiratory monitoring applications is improving adoption of respiratory monitoring systems worldwide.

Growing investments from healthcare providers, medical device manufacturers, and digital health companies in respiratory care technologies, portable monitoring devices, and smart healthcare infrastructure are accelerating market growth.

Rising awareness regarding early disease detection, preventive healthcare, and continuous respiratory assessment is further propelling global respiratory monitoring market expansion.

Industry Developments

Rapid advancement in AI-enabled respiratory monitoring platforms and smart wearable technologies improving real-time patient tracking, predictive analytics, and clinical decision-making.

Increasing adoption of portable respiratory monitoring devices and wireless patient monitoring systems supporting efficient home-based and remote healthcare management.

Growing investments in cloud-connected respiratory monitoring infrastructure, telemedicine integration, and digital healthcare ecosystems accelerating innovation across the respiratory care industry.

Expansion of non-invasive respiratory monitoring technologies and multi-parameter monitoring systems improving patient comfort, operational efficiency, and long-term disease management.

Rising collaborations among healthcare institutions, medical device manufacturers, software developers, and research organizations driving development of integrated respiratory care solutions.

Strategic product launches and commercialization of advanced capnography systems, pulse oximeters, spirometers, and respiratory monitoring wearables supporting global market expansion.

Continuous innovation in sensor technologies, machine learning algorithms, and real-time respiratory analytics improving monitoring accuracy, workflow optimization, and healthcare efficiency.

Regional Insights

North America 38.4% share: "Leads the market due to advanced healthcare infrastructure, high adoption of remote patient monitoring technologies, increasing prevalence of respiratory diseases, and strong presence of major medical device manufacturers."

Europe 24.1% share: "Growth supported by expanding geriatric population, rising healthcare expenditure, increasing adoption of digital health technologies, and strong regulatory focus on patient safety and chronic disease management."

Asia Pacific 28.7% share: "Fastest-growing region driven by rapid healthcare infrastructure development, growing respiratory disease burden, increasing investments in healthcare digitization, and rising demand for affordable monitoring solutions across China, India, Japan, and Southeast Asia."

Latin America 5.3% share: "Strong growth supported by improving healthcare access, increasing awareness regarding respiratory disease management, and growing investments in hospital monitoring infrastructure."

Middle East & Africa 3.5% share: "Gradual growth driven by expanding healthcare modernization initiatives, rising prevalence of respiratory disorders, and increasing adoption of advanced patient monitoring technologies across hospitals and clinics."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/-respiratory-monitoring-market?sai-v

Key Segments
➥ By Product Type

Diagnostic Devices: Represents a dominant segment, driven by increasing demand for accurate pulmonary function assessment and early diagnosis of respiratory disorders across healthcare settings.

Spirometers: Represents a major segment, supported by rising utilization in diagnosing asthma, chronic obstructive pulmonary disease (COPD), and other lung function abnormalities.

Peak Flow Meters: Represents a significant segment, fueled by growing adoption for routine monitoring of asthma patients and home-based respiratory care management.

Monitoring Devices: Represents a rapidly growing segment, driven by increasing need for continuous respiratory monitoring in critical care, sleep diagnostics, and emergency medicine.

Sleep Test Devices: Represents a major segment, supported by rising prevalence of sleep apnea and growing demand for home sleep testing and polysomnography procedures.

Gas Analyzers: Represents a significant segment, fueled by increasing use in anesthesia monitoring, pulmonary diagnostics, and intensive care respiratory assessment.

Pulse Oximeters: Represents the dominant segment, driven by widespread utilization for non-invasive oxygen saturation monitoring in hospitals, clinics, and home healthcare environments.

Capnography: Represents a rapidly growing segment, supported by increasing adoption in surgical procedures, emergency care, and critical patient monitoring applications.

➥ By End-user

Hospitals: Represents the dominant segment, driven by increasing patient admissions related to respiratory disorders and growing adoption of advanced respiratory monitoring technologies in critical care units.

Laboratories: Represents a significant segment, supported by rising demand for pulmonary diagnostic testing, sleep studies, and respiratory disease analysis across clinical laboratories and diagnostic centers.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.